Sen. Markwayne Mullin disclosed purchasing as much as $100,000 worth of shares in UnitedHealth Group, the nation’s largest health insurer, according to a recent congressional financial filing.
The Oklahoma Republican reported buying between $50,000 and $100,000 of UNH on Feb. 25, 2026. Based on the midpoint of the disclosure range, the investment is worth roughly $75,000. UnitedHealth currently trades around $282.09 per share, giving the healthcare giant a market capitalization of about $256 billion.
The transaction adds to Mullin’s broader portfolio of congressional trades. Financial disclosure records show the senator has reported 73 trades during his career in Congress.
Details of the trade
- Lawmaker: Sen. Markwayne Mullin (R-Okla.)
- Stock: UnitedHealth Group (UNH)
- Transaction: Buy
- Date: Feb. 25, 2026
- Amount: $50,000–$100,000
- Reported owner: JT
- Estimated value: ~$75,000
UnitedHealth is widely considered a bellwether for the U.S. healthcare system. Through its UnitedHealthcare insurance division and its Optum health services arm, the company touches nearly every segment of the industry—from Medicare Advantage plans and employer coverage to pharmacy benefit management and physician networks.
Because of that reach, the company’s earnings often serve as an early signal for broader trends in medical costs, healthcare utilization, and federal reimbursement policy. Investors closely track UnitedHealth’s outlook for clues about Medicare Advantage enrollment, government payment rates, and the financial health of hospitals and physician groups.
Committee role intersects with healthcare policy
Mullin serves on the Senate Committee on Health, Education, Labor, and Pensions (HELP), which handles major legislation affecting healthcare coverage, workplace health rules, and public health programs. The committee has jurisdiction over agencies including the Department of Health and Human Services and regularly considers legislation shaping insurance markets and healthcare delivery.
He also sits on the Senate Appropriations Committee and several of its subcommittees, which oversee federal spending across agencies including those tied to health and regulatory policy.
Those assignments place Mullin among the lawmakers who can influence policy environments that affect large insurers like UnitedHealth—from Medicare program funding to broader healthcare regulatory frameworks.
UnitedHealth a frequent pick on Capitol Hill
Mullin is far from the only member of Congress to trade shares of the healthcare giant. At least 83 lawmakers have reported transactions in UnitedHealth stock, reflecting the company’s status as one of the most widely held healthcare names in congressional portfolios.
The stock’s size and diversification make it a common institutional holding. UnitedHealth’s scale across insurance coverage, pharmacy benefits, and care delivery also positions it at the center of debates over healthcare costs and government reimbursement policy.
Congressional trading activity has drawn heightened scrutiny in recent years, particularly when lawmakers buy or sell shares in industries affected by legislation they oversee. Under the STOCK Act, members of Congress must disclose stock trades within 45 days.
Mullin’s UnitedHealth purchase appeared in that required disclosure system alongside other filings that track the latest congressional trades reported by lawmakers.